Brief: SSY Group's Acipimox And Diprophylline Obtained Approvals For Registration From NMPA
22/04/2025 15:22
April 22 (Reuters) - SSY Group Ltd 2005.HK: GROUP'S ACIPIMOX AND DIPROPHYLLINE OBTAINED APPROVALS FOR REGISTRATION FROM NMPA OBTAINED APPROVALS FOR DRUG PRODUCTION, OTHERS,FOR DAPAGLIFLOZIN & METFORMIN HYDROCHLORIDE SUSTAINED-RELEASE TABLETS, OTHERS,FROM NMPA Further company coverage: 2005.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth